NXTC
NextCure, Inc. - Common Stock (NXTC)
$60
About NextCure, Inc. - Common Stock (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
Details
Daily high
$10.99
Daily low
$9.49
Price at open
$10.30
52 Week High
$15.74
52 Week Low
$2.69
Market cap
37.1M
Dividend yield
0.00%
Volume
41,626
Avg. volume
36,925
P/E ratio
-.48
NextCure, Inc. - Common Stock News
Details
Daily high
$10.99
Daily low
$9.49
Price at open
$10.30
52 Week High
$15.74
52 Week Low
$2.69
Market cap
37.1M
Dividend yield
0.00%
Volume
41,626
Avg. volume
36,925
P/E ratio
-.48